Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inclisiran
Marketing
Novartis wins Leqvio nod, aims to avoid pitfalls of other PCSK9s
Novartis expects over $2 billion peak sales for Leqvio, a PCSK9-targeted RNA interference therapy.
Angus Liu
Dec 22, 2021 8:55pm
Novartis targets 20 blockbuster launches by 2026
Dec 2, 2021 10:16am
Analyst puts Amgen's Otezla, Repatha, biosimilars on notice
Nov 22, 2021 11:10am
Novartis teams with advocacy group to bring visibility to ASCVD
Nov 2, 2021 4:05pm
Amgen's Repatha gains FDA nod for genetic cholesterol disorder
Sep 27, 2021 9:56am
Novartis, NHS move forward with 'landmark' Leqvio access deal
Aug 31, 2021 7:01pm
